Metabolic Signaling in Cancer.


Journal

Cold Spring Harbor perspectives in medicine
ISSN: 2157-1422
Titre abrégé: Cold Spring Harb Perspect Med
Pays: United States
ID NLM: 101571139

Informations de publication

Date de publication:
10 Jun 2024
Historique:
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 10 6 2024
Statut: aheadofprint

Résumé

Metabolic reprogramming in cancer allows cells to survive in harsh environments and sustain macromolecular biosynthesis to support proliferation. In addition, metabolites play crucial roles as signaling molecules. Metabolite fluctuations are detected by various sensors in the cell to regulate gene expression, metabolism, and signal transduction. Metabolic signaling mechanisms contribute to tumorigenesis by altering the physiology of cancer cells themselves, as well as that of neighboring cells in the tumor microenvironment. In this review, we discuss principles of metabolic signaling and provide examples of how cancer cells take advantage of metabolic signals to promote cell proliferation and evade the immune system, thereby contributing to tumor growth and progression.

Identifiants

pubmed: 38858082
pii: cshperspect.a041544
doi: 10.1101/cshperspect.a041544
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Cold Spring Harbor Laboratory Press; all rights reserved.

Auteurs

Laura V Pinheiro (LV)

Department of Cancer Biology, Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.
Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.
Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Pedro Costa-Pinheiro (P)

Department of Cancer Biology, Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.
Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Kathryn E Wellen (KE)

Department of Cancer Biology, Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA wellenk@upenn.edu.
Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Classifications MeSH